Treatment of scleromyxedema Arndt-Gottron with a novel intravenous immunoglobulin preparation
Dermatology Reports · 14.04.2026
DOI: 10.4081/dr.2026.10557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Reports, online erschienen am 14.04.2026. Verfasst von Niklas Negele und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Heidelberg. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Dear Editor, Scleromyxedema is known as a rare, severe mucinosis with characteristic waxy skin papules along with sclerodermiform induration of the skin and rare systemic manifestations. Monoclonal gammopathy of undetermined significance (MGUS; mostly monoclonal immunoglobulin G [IgG] type lambda) can be detected in up to 90% of patients. [...]
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, University Hospital Heidelberg.
Zitieren
APA
Negele, N., Winkler, J. K., & Enk, A. H. (2026). Treatment of scleromyxedema Arndt-Gottron with a novel intravenous immunoglobulin preparation. Dermatology Reports. https://doi.org/10.4081/dr.2026.10557
Vancouver
Negele N, Winkler JK, Enk AH. Treatment of scleromyxedema Arndt-Gottron with a novel intravenous immunoglobulin preparation. Dermatology Reports. 2026. doi:10.4081/dr.2026.10557
BibTeX
@article{Negele2026,
author = {Negele, Niklas and Winkler, Julia K and Enk, Alexander H},
title = {Treatment of scleromyxedema Arndt-Gottron with a novel intravenous immunoglobulin preparation},
journal = {Dermatology Reports},
year = {2026},
doi = {10.4081/dr.2026.10557}
}
EUVIMED